Agency Information Collection Request: 30-Day Public Comment Request, 54757-54758 [2018-23777]
Download as PDF
54757
Federal Register / Vol. 83, No. 211 / Wednesday, October 31, 2018 / Notices
from the public will be scheduled
between approximately 1:15 p.m. and
2:15 p.m. on December 4, 2018. Those
individuals interested in making formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before November 19, 2018. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
November 19, 2018.
Closed Committee Deliberations: On
December 4, 2018, from 5:45 p.m. to
6:00 p.m., and December 5, 2018, from
11:30 a.m. to 12:00 p.m., the meeting
will be closed to permit discussion
where disclosure would constitute a
clearly unwarranted invasion of
personal privacy (5 U.S.C. 552b(c)(6)).
This portion of the meeting will be
closed to permit discussion of
information concerning individuals
associated with the research programs at
NCTR.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Donna
Mendrick at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: October 25, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–23742 Filed 10–30–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–0313]
Agency Information Collection
Request: 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before November 30,
2018.
SUMMARY:
Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990–0313–30D and project title for
reference.
ADDRESSES:
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
SUPPLEMENTARY INFORMATION:
Number of
respondents
amozie on DSK3GDR082PROD with NOTICES1
Type of respondent
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: The Nation
Blood Collection & Utilization Survey
(NBCUS).
Type of Collection: Extension on a
previously approved collection.
OMB No. 0990–0313- Office of the
Assistant Secretary for Health—Office of
HIV/AIDS and Infectious Disease Policy
(OHAIDP).
Abstract: Length of request: 3 years.
The Nation Blood Collection &
Utilization Survey (NBCUS) is a
biennial survey of the blood collection
and utilization community to produce
reliable and accurate estimates of
national and regional collections,
utilization and safety of all blood
products. The 2019 NBCUS is funded by
Department of Health and Human
Services (DHHS/OASH) and performed
by the Centers for Disease Control and
Prevention (CDC). In previous years, a
similar survey was performed under the
auspices of the National Blood Data
Resource Center (NBDRC), a private
subsidiary of AABB (formerly known as
the American Association of Blood
Banks), with private funding. In 2005,
2007, 2009, and 2011 the survey was
funded by HHS/OS/OASH and
performed under contract by AABB. The
CDC has since performed the 2013,
2015, and 2017 iterations of the NBCUS.
Type of respondent: U.S. Blood
Collection Centers (number sampled:
70), U.S. Hospital Blood Banks (number
sampled: 2850); frequency: biennial;
and the affected public: private
businesses.
Estimated Annualized Burden Table
Number
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Hospital Blood Banks ......................................................................................
Blood Collection Centers .................................................................................
2850
70
1
1
2
2
5700
140
Total ..........................................................................................................
2920
........................
........................
5840
VerDate Sep<11>2014
18:06 Oct 30, 2018
Jkt 247001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\31OCN1.SGM
31OCN1
54758
Federal Register / Vol. 83, No. 211 / Wednesday, October 31, 2018 / Notices
Terry Clark,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 2018–23777 Filed 10–30–18; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meetings
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Innovations for
Health Living—Improving Minority Health
and Eliminating Health Disparities.
Date: December 4, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Minority
Health and Health Disparities, 7201
Wisconsin Ave., Suite 525, Rm. 533K,
Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Xinli Nan, Ph.D., Scientific
Review Officer, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, Scientific
Review Branch, OERA, 7201 Wisconsin Ave.,
Suite 525, Bethesda, MD 20814, (301) 594–
7784, Xinli.Nan@nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; RCMI Research
Coordinating Network (RRCN) (U54).
Date: December 12, 2018.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gateway Building, 7201 Wisconsin
Ave, Suite 533, Bethesda, MD 20814 (Virtual
Meeting).
Contact Person: Maryline Laude-Sharp,
Ph.D., Scientific Review Officer, National
Institute on Minority Health and Health
Disparities, National Institutes of Health,
7201 Wisconsin Ave., Bethesda, MD 20814,
(301) 451–9536, mlaudesharp@nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
VerDate Sep<11>2014
18:06 Oct 30, 2018
Jkt 247001
Special Emphasis Panel; Special Emphasis
Panel for Review of Research Conference
(R13) Grant Applications.
Date: December 10, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 7201 Wisconsin Avenue,
Bethesda, MD 20817.
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institute on
Minority Health and Health Disparities,
Gateway Plaza, 7201 Wisconsin Avenue,
Bethesda, MD 20817, (301) 594–2704,
ismonddr@mail.nih.gov.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4128, Bethesda, MD 20892, 301–
435–1850, limc4@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 25, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: October 25, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–23738 Filed 10–30–18; 8:45 am]
[FR Doc. 2018–23740 Filed 10–30–18; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
National Institute of Nursing Research;
Notice To Close Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; High-End
(PAR 18–598) and Shared (PAR 18–600)
Instrumentation Grant Programs: Electron
Microscopes and Ancillary Equipment.
Date: November 19–20, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiovascular Sciences.
Date: November 28–29, 2018.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Lasker Clinical Research Scholars Program.
Date: November 5, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Boulevard, 6701 Democracy
Boulevard, Suite 703, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Weiqun Li, MD, Scientific
Review Officer, National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, Suite 710, Bethesda,
MD 20892, (301) 594–5966, wli@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\31OCN1.SGM
31OCN1
Agencies
[Federal Register Volume 83, Number 211 (Wednesday, October 31, 2018)]
[Notices]
[Pages 54757-54758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23777]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-0313]
Agency Information Collection Request: 30-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before November 30,
2018.
ADDRESSES: Submit your comments to [email protected] or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected]
or (202) 795-7714. When submitting comments or requesting information,
please include the document identifier 0990-0313-30D and project title
for reference.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: The Nation Blood Collection & Utilization
Survey (NBCUS).
Type of Collection: Extension on a previously approved collection.
OMB No. 0990-0313- Office of the Assistant Secretary for Health--
Office of HIV/AIDS and Infectious Disease Policy (OHAIDP).
Abstract: Length of request: 3 years. The Nation Blood Collection &
Utilization Survey (NBCUS) is a biennial survey of the blood collection
and utilization community to produce reliable and accurate estimates of
national and regional collections, utilization and safety of all blood
products. The 2019 NBCUS is funded by Department of Health and Human
Services (DHHS/OASH) and performed by the Centers for Disease Control
and Prevention (CDC). In previous years, a similar survey was performed
under the auspices of the National Blood Data Resource Center (NBDRC),
a private subsidiary of AABB (formerly known as the American
Association of Blood Banks), with private funding. In 2005, 2007, 2009,
and 2011 the survey was funded by HHS/OS/OASH and performed under
contract by AABB. The CDC has since performed the 2013, 2015, and 2017
iterations of the NBCUS.
Type of respondent: U.S. Blood Collection Centers (number sampled:
70), U.S. Hospital Blood Banks (number sampled: 2850); frequency:
biennial; and the affected public: private businesses.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Hospital Blood Banks............................ 2850 1 2 5700
Blood Collection Centers........................ 70 1 2 140
---------------------------------------------------------------
Total....................................... 2920 .............. .............. 5840
----------------------------------------------------------------------------------------------------------------
[[Page 54758]]
Terry Clark,
Office of the Secretary, Paperwork Reduction Act Reports Clearance
Officer.
[FR Doc. 2018-23777 Filed 10-30-18; 8:45 am]
BILLING CODE 4150-41-P